{"id":163833,"date":"2022-10-11T02:07:51","date_gmt":"2022-10-11T06:07:51","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/ab-science-receives-first-agencies-authorizations-to-initiate-confirmatory-phase-3-clinical-study-with-masitinib-in-the-treatment-of-alzheimers\/"},"modified":"2024-08-18T11:45:45","modified_gmt":"2024-08-18T15:45:45","slug":"ab-science-receives-first-agencies-authorizations-to-initiate-confirmatory-phase-3-clinical-study-with-masitinib-in-the-treatment-of-alzheimers","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/ab-science-receives-first-agencies-authorizations-to-initiate-confirmatory-phase-3-clinical-study-with-masitinib-in-the-treatment-of-alzheimers.php","title":{"rendered":"AB Science receives first agencies authorizations to initiate confirmatory Phase 3 clinical study with masitinib in the treatment of Alzheimer\u2019s&#8230;"},"content":{"rendered":"<p><![CDATA[PRESS RELEASE]]><\/p>\n<p>See more here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/10\/10\/2531253\/0\/en\/AB-Science-receives-first-agencies-authorizations-to-initiate-confirmatory-Phase-3-clinical-study-with-masitinib-in-the-treatment-of-Alzheimer-s-disease.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"AB Science receives first agencies authorizations to initiate confirmatory Phase 3 clinical study with masitinib in the treatment of Alzheimer\u2019s...\">AB Science receives first agencies authorizations to initiate confirmatory Phase 3 clinical study with masitinib in the treatment of Alzheimer\u2019s...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See more here: AB Science receives first agencies authorizations to initiate confirmatory Phase 3 clinical study with masitinib in the treatment of Alzheimer\u2019s... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/ab-science-receives-first-agencies-authorizations-to-initiate-confirmatory-phase-3-clinical-study-with-masitinib-in-the-treatment-of-alzheimers.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-163833","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163833"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=163833"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163833\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=163833"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=163833"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=163833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}